当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析

万孚生物

(300482)

  

流通市值:90.90亿  总市值:101.68亿
流通股本:4.30亿   总股本:4.81亿

万孚生物(300482)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.90亿元,每股收益0.39元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益584022.33万元,未分配利润373500.91万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产718254.59万元,负债134232.26万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入800,275,782.513,064,809,396.662,181,361,474.641,575,250,376.82
营业总成本588,132,685.222,433,963,779.681,715,728,355.951,184,260,271.92
营业利润215,606,151.09636,845,288.18498,107,917.74407,220,756.33
利润总额215,017,806.11629,462,610.16492,835,920.6405,345,826.26
净利润190,072,222.04565,215,133.8439,816,270.6358,314,750.06
其他综合收益-27,967.44-27,150,639.65-222,870.57736,513.98
综合收益总额190,044,254.6538,064,494.15439,593,400.03359,051,264.04
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计3,824,674,042.043,785,861,965.83,757,526,923.23,667,825,221.88
非流动资产合计3,357,871,870.493,368,790,077.332,992,527,070.682,996,006,516.98
资产总计7,182,545,912.537,154,652,043.136,750,053,993.886,663,831,738.86
流动负债合计661,546,113.92821,464,141504,768,504.72489,656,308.49
非流动负债合计680,776,518.41682,899,896.54678,650,808.68702,261,883.64
负债合计1,342,322,632.331,504,364,037.541,183,419,313.41,191,918,192.13
归属于母公司股东权益合计5,743,386,505.555,554,388,042.845,470,222,938.095,376,867,685.32
股东权益合计5,840,223,280.25,650,288,005.595,566,634,680.485,471,913,546.73
负债和股东权益合计7,182,545,912.537,154,652,043.136,750,053,993.886,663,831,738.86
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计557,099,837.332,601,230,864.981,949,008,494.631,401,150,853.3
经营活动现金流出小计705,887,556.912,239,519,734.121,775,685,214.491,200,791,423.83
经营活动产生的现金流量净额-148,787,719.58361,711,130.86173,323,280.14200,359,429.47
投资活动现金流入小计1,268,202,362.964,521,693,638.42,952,447,043.561,579,930,668.97
投资活动现金流出小计1,643,899,089.575,538,290,314.654,345,699,320.972,723,735,958.23
投资活动产生的现金流量净额-375,696,726.61-1,016,596,676.25-1,393,252,277.41-1,143,805,289.26
筹资活动现金流入小计2,386,986.95883,364,758.44868,154,476.56696,297,887.06
筹资活动现金流出小计160,000244,286,833.79223,376,534.22201,000,584.65
筹资活动产生的现金流量净额2,226,986.95639,077,924.65644,777,942.34495,297,302.41
汇率变动对现金及现金等价物的影响237,482.294,332,842.78-850,686.91,551,346.07
现金及现金等价物净增加额-522,019,976.95-11,474,777.96-576,001,741.83-446,597,211.31
期末现金及现金等价物余额306,083,051.7828,103,028.65263,576,064.78392,980,595.3
最新报告期:2025-05-14
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,李婵娟1.341.551.792025-05-14
中信证券宋硕,陈竹1.341.511.702025-04-29
华泰证券代雯,高鹏,杨昌源1.351.561.802025-04-24
太平洋谭紫媚1.341.601.862025-04-18
中国银河孟熙,程培1.341.561.812025-04-12
TOP↑